CIK 0001576885 · <br>Emerging growth company
Acumen Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ABOS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364108129
- Phone
- 617-344-4190
- Business address
- 1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-29 | Zuga Matt CFO and Chief Business Officer | Option exercise | +50,000 | $1.19 | $60K | 76,187 |
| 2022-12-29 | Zuga Matt CFO and Chief Business Officer | Option exercise · Stock Option (right to buy) | −50,000 | 401,369 | ||
| 2022-09-06 | Meisner Derek M Chief Legal Office & Corp Sec | Grant or award · Employee Stock Option (right to buy) | +225,000 | 225,000 | ||
| 2022-06-15 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-15 | Fountain Nathan B Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-15 | Stoppel Laura Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-15 | Ives Jeffrey L. Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-15 | Stalfort John A III Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-15 | Sevigny Jeffrey Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-06-15 | Drapkin Kimberlee C Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-04-01 | Drapkin Kimberlee C Director | Grant or award · Stock Option Grant (right to buy) | +50,000 | 50,000 | ||
| 2022-01-19 | Zuga Matt CFO and Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2022-01-19 | Siemers Eric Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2022-01-19 | OConnell Daniel Joseph President and CEO | Grant or award · Employee Stock Option (right to buy) | +455,000 | 455,000 | ||
| 2022-01-19 | Barton Russell Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +135,000 | 135,000 | ||
| 2021-11-30 | OConnell Daniel Joseph President and CEO | Option exercise | +1,118 | $4.47 | $5K | 2,685 |
| 2021-11-30 | OConnell Daniel Joseph President and CEO | Option exercise · Stock Option (Right to Buy) | −1,118 | 0 | ||
| 2021-07-06 | Manning Paul B 10% owner | Conversion | +2,950,484 | 3,040,193 | ||
| 2021-07-06 | Manning Paul B 10% owner | Purchase | +312,500 | $16.00 | $5.0M | 3,352,693 |
| 2021-07-06 | Manning Paul B 10% owner | Conversion | +657,985 | 657,985 |
Page 10 of 13 · 246 trades